Evolent Health, Inc.
EVH
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $485.9M
$4.32
▲ +1.41%
P/E
—
Mkt Cap
$485.9M
52-Wk Range
$2.10–$10.08
52-Week Range
$2.10 - $10.08
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 55.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Identifi technology platform that aggregates data, manages workflows, and enables patient engagement at scale
- Dual expertise spanning both payer and provider perspectives, enabling comprehensive end-to-end solutions
- Established relationships with major health plans and healthcare systems built over 12+ years of operations
- Specialized clinical capabilities in high-cost specialty care areas (oncology and cardiology) with proven cost management track records
Bear Case
2 risks
- Average volatility.
- Premium valuation to Healthcare IT & Services peers
Growth
Turning profitable
Industry-wide shift from fee-for-service to value-based care models creating sustained demand for transition solutions
Value
Premium valuation to Healthcare IT & Services peers
Momentum
Weak
-7.3% over 3m
Quality
Thin
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying EVH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $0.02 vs -$0.01 consensus (+292.1% surprise). Revenue of $652.5M vs $597.7M expected (+9.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+292.1%
Revenue trend · last 8Q
—
+16%
-24%
-31%
-23%
-28%
+3%
+47%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$621.4M
$646.5M
$483.6M
$444.3M
$479.5M
$468.7M
$496.2M
$652.5M
Margins · last 8Q
Gross
12.4%
Operating
-1.5%
Profit
-4.3%
Wall Street consensus
4 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 10, 2026
vs Industry
How EVH stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related